| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |